ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - January 1920

Decade

Year

Issue

February 2022, Vol 158, No. 2, Pages 122-219

Editorial

Radiologic Imaging for High-Stage Cutaneous Squamous Cell Carcinomas

Abstract Full Text
JAMA Dermatol. 2022;158(2):125-126. doi:10.1001/jamadermatol.2021.4989
Original Investigation

Patient Impressions and Outcomes After Clinic-Based Hidradenitis Suppurativa Surgery

Abstract Full Text
free access has audio
JAMA Dermatol. 2022;158(2):132-141. doi:10.1001/jamadermatol.2021.4741

This cohort study assesses patient impressions, outcomes, and recovery time after clinic-based surgery for hidradenitis suppurativa and the association of patient characteristics with outcomes.

Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis: 1-Year Results From the RELIEVE-AD Study

Abstract Full Text
open access
JAMA Dermatol. 2022;158(2):142-150. doi:10.1001/jamadermatol.2021.4778

This cohort study evaluates self-reported disease control and quality of life after initiating dupilumab treatment in patients with atopic dermatitis in the clinical setting.

Assessment of the Diagnostic Accuracy of Baseline Clinical Examination and Ultrasonographic Imaging for the Detection of Lymph Node Metastasis in Patients With High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck

Abstract Full Text
free access
JAMA Dermatol. 2022;158(2):151-159. doi:10.1001/jamadermatol.2021.4990

This diagnostic study assesses the diagnostic accuracy of clinical examination and ultrasonography for the detection of high-risk cutaneous squamous cell carcinoma of the head and neck and the accuracy of ultrasonography when baseline clinical examination produces negative findings.

Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis: The Role of Novel Inflammatory Markers and Proposed Revision of SCORTEN (Re-SCORTEN)

Abstract Full Text
free access
JAMA Dermatol. 2022;158(2):160-166. doi:10.1001/jamadermatol.2021.5119

This cohort study assesses the predictive accuracy of red blood cell distribution width to hemoglobin ratio compared with the Severity-of-Illness Score for Toxic Epidermal Necrolysis for in-hospital mortality rates for patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid

Abstract Full Text
free access
JAMA Dermatol. 2022;158(2):167-175. doi:10.1001/jamadermatol.2021.5125

This cohort study assesses the association of all-cause, cardiovascular disease, and cancer mortality with bullous pemphigoid among patients treated at a dermatology clinic.

Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US

Abstract Full Text
free access has active quiz
JAMA Dermatol. 2022;158(2):176-183. doi:10.1001/jamadermatol.2021.5390

This case series examines the development of acute generalized exanthematous pustulosis.

Brief Report

Drug Survival of Biologics in Patients With Hidradenitis Suppurativa

Abstract Full Text
has audio
JAMA Dermatol. 2022;158(2):184-188. doi:10.1001/jamadermatol.2021.4805

This cohort study examines the drug survival of biologic therapies for Danish patients with hidradenitis suppurativa.

Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Therapy

Abstract Full Text
JAMA Dermatol. 2022;158(2):189-193. doi:10.1001/jamadermatol.2021.5476

This cohort study examines the association of developing cutaneous immune-related adverse events following treatment with anti–PD-1 or anti–PD-L1 therapy with patient survival.

JAMA Dermatology Clinical Evidence Synopsis

Interventions for Cutaneous Disease in Systemic Lupus Erythematosus: Summary of a Cochrane Review

Abstract Full Text
JAMA Dermatol. 2022;158(2):200-201. doi:10.1001/jamadermatol.2021.5485

This Clinical Evidence Synopsis presents key findings from a Cochrane review of interventions for cutaneous disease in systemic lupus erythematosus.

Images in Dermatology

Pyoderma Gangrenosum

Abstract Full Text
JAMA Dermatol. 2022;158(2):202. doi:10.1001/jamadermatol.2021.5001

This case report describes ulcerative plaques with ill-defined, violaceous, and undermined borders with cribriform scarring.

Late-Onset Congenital Erythropoietic Porphyria

Abstract Full Text
JAMA Dermatol. 2022;158(2):203. doi:10.1001/jamadermatol.2021.5005

This case report describes clear vesicles and erosions on dorsal hands, upper chest, ears, and neck.

JAMA Dermatology Clinicopathological Challenge

Recurrent Photosensitive Pustular Eruption in a Young Woman

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(2):204-205. doi:10.1001/jamadermatol.2021.5383

A woman in her 20s presented with a 4-year history of recurrent pustular eruptions on her face appearing as erythematous papules with prominent pustules and exacerbated by sunlight. What is your diagnosis?

Multiple Craniofacial Nodules and Plaques Distributed Bilaterally Along Blaschko Lines

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(2):206-207. doi:10.1001/jamadermatol.2021.5474

A male in his late teens presented with asymptomatic congenital papules, plaques, and nodules in a linear bilateral distribution following Blaschko lines on the scalp and face region. What is your diagnosis?

Research Letter

Autoreactivity to BP180 Neoepitopes in Patients With Pemphigoid Gestationis

Abstract Full Text
free access
JAMA Dermatol. 2022;158(2):212-214. doi:10.1001/jamadermatol.2021.5294

This case series characterizes immune profiles of pregnant people with pemphigoid gestationis.

Observation

Improvement of Cutaneous Hereditary Hemorrhagic Telangiectasia With Pazopanib—A Multikinase Inhibitor

Abstract Full Text
JAMA Dermatol. 2022;158(2):214-216. doi:10.1001/jamadermatol.2021.5132

This case report describes a patient with hereditary hemorrhagic telangiectasia that was complicated by cutaneous telangiectasias, gastrointestinal arteriovenous malformations with bleeding, nosebleeds, and liver and pulmonary arteriovenous malformations.

Treatment of Keratin 16 Palmoplantar Keratoderma With Topical Erlotinib

Abstract Full Text
JAMA Dermatol. 2022;158(2):216-217. doi:10.1001/jamadermatol.2021.5302

This case report describes a mother and son with hereditary palmoplantar keratoderma.

Comment & Response

Chilblains and COVID-19—An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines

Abstract Full Text
free access
JAMA Dermatol. 2022;158(2):217-218. doi:10.1001/jamadermatol.2021.5172

Chilblains and COVID-19—An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines—Reply

Abstract Full Text
free access
JAMA Dermatol. 2022;158(2):218-219. doi:10.1001/jamadermatol.2021.4449
Correction

Errors in Results Section

Abstract Full Text
free access
JAMA Dermatol. 2022;158(2):219. doi:10.1001/jamadermatol.2021.5451

Error in Author Listing and Affiliation

Abstract Full Text
free access
JAMA Dermatol. 2022;158(2):219. doi:10.1001/jamadermatol.2022.0056
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2022;158(2):122. doi:10.1001/jamadermatol.2021.4189
×